Developing highly active and low-cost electrocatalysts for the oxygen evolution reaction (OER) to meet industrial criteria is vitally essential.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: